| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2009;40:2298.)
© 2009 American Heart Association, Inc.
Original Contributions |
From University Department of Medicine (A.G., G.Y.H.L.), City Hospital, Birmingham, England, UK; Sandwell Medical Research Unit (J.V.P., B.G., E.A.H.), Sandwell General Hospital, West Bromwich, UK.
Correspondence to Professor G.Y.H. Lip, University Department of Medicine, City Hospital, Birmingham, B18 7QH, England, UK. E-mail g.y.h.lip{at}bham.ac.uk
| Abstract |
|---|
|
|
|---|
Methods— Using a cross-sectional approach, a total of 100 SA stroke survivors were prospectively recruited from the ongoing West Birmingham Stroke Project. Indices of vessel wall characteristics (arterial stiffness and endothelial function [change in reflective index]) were measured noninvasively using the digital volume pulse analysis technique in a temperature-controlled environment, using a direct standardized approach. SA stroke subjects were compared to 60 EC stroke survivors, 60 SA with risk factors, and 73 healthy controls.
Results— Among stroke patients, both ethnic groups were comparable for cardiovascular risk profile, except for more diabetes mellitus in SA (P=0.007) subjects and a higher prevalence of atrial fibrillation in EC (P=0.04) subjects. According to the TOAST and Bamford classifications, SA subjects had more small vessel (P=0.04) and lacunar infarctions (P=0.01). SA subjects had higher measurements of arterial stiffness (P<0.001) and impaired endothelial-dependent vascular function (change in reflective index %; P<0.001). On univariate analysis, endothelial function was negatively correlated with fasting plasma glucose (r=–0.4; P<0.001) and total cholesterol level (r=–0.2; P<0.001). On multivariate analysis, glycemic status was independently associated with impaired endothelial function (P=0.008) and increased arterial stiffness (P<0.001) among SA subjects.
Conclusion— SA stroke survivors had more small vessel disease-related cerebrovascular events compared to EC subjects. Underlying glycemic status in SA subjects had an adverse impact on the vascular system, leading to abnormal vessel wall characteristics.
Key Words: arterial stiffness endothelial function glycemic status South Asian
| Introduction |
|---|
|
|
|---|
Indices of arterial stiffness and endothelial dysfunction are accepted as independent markers of vascular disease, having both prognostic and diagnostic implications.9,10 Established cerebrovascular disease risk factors such as diabetes and hypercholesterolemia are known to alter the underlying vessel wall characteristics,11 causing impaired endothelial function12 and increased arterial stiffness,12 with a consequent increase in greater cerebrovascular disease risk.13,14 South Asian stroke survivors in the United Kingdom have an increased prevalence of diabetes and hypertension,7 and it is likely that these established risk indices exert an adverse impact on the vessel wall characteristics of these individuals.
The objective of the present study was to test the hypothesis that indices of arterial stiffness and endothelial dysfunction are higher in South Asian stroke survivors compared to European Caucasians, and to investigate whether conventional cerebrovascular disease risk indices are able to explain these vessel wall abnormalities.
| Materials and Methods |
|---|
|
|
|---|
South Asians were defined by self-reported ethnicity as being Indian, Pakistani, Sri Lankan, Nepalese, and Bangladeshi, and whose grandparents (at least 3) also originated from the Indian subcontinent. Information from the 2001 census revealed that between 20% and 25% of the 300 000 population of Sandwell are from ethnic minority groups (including Bangladeshi [1.21%], Indian [9.14%], and Pakistani [2.95%] populations).23 Using a stratified representative sampling approach, controls were also recruited from the same catchment area as the stroke patients (Sandwell and West Birmingham, West Midlands, United Kingdom). The total cohort (age 30–75 years) comprised people with and without any known established cardiovascular risk factors. South Asian risk factor controls were assessed clinically and included the following criteria: evidence of abnormal mean blood pressure measurement (>140/90 mm Hg), increased fasting plasma glucose (>7.0 mmol/L), increased serum cholesterol (>5.5 mmol/L), or documented evidence of cardiovascular disease (hypertension, diabetes mellitus, hyperlipidemia), but without any cerebrovascular disease (stroke or TIA) or ischemic heart disease (MI, coronary artery bypass graft, or percutaneous coronary intervention). Hence, subjects who were without any of these risk factors and who were not using any regularly prescribed cardiovascular medications at the time of entry into the study were considered as healthy controls.
Systolic and diastolic brachial arterial blood pressure levels were measured with the validated semiautomatic Omron HEM-705CP (Omron Healthcare Europe). Fasting plasma glucose levels and cholesterol levels were measured using an auto analyser (Roche COBAS INTEGRA 800).
Measurements of Arterial Stiffness
Arterial stiffness was measured using the digital volume pulse analysis (DVP) technique. The DVP analysis method is a noninvasive technique of measuring pulse wave reflections to determine the arterial stiffness peripherally.24 Arterial stiffness using this has been proven to be a validated, reproducible technique25 with minimal intraobserver variation.29 The stiffness index derived from this method has been demonstrated to have a good correlation to pulse wave velocity,26 whereas the sensitivity and specificity of this technique are comparable to the pulse wave velocity method in the identification of patients with latent cardiovascular disease.27,28
Measurement of Endothelial Function
The reflective index (RI) is a parameter derived from the analysis of the DVP. Similar to other noninvasive measurements such as flow-mediated dilatation, this is an indirect method of determining endothelial function peripherally.29,30 Endothelium-dependent vessel function can be determined by calculating the relative change in reflective index (
RI%) after the administration of a nitric oxide (NO) releasing β2-receptor stimulant agent such as Salbutamol.29 For comparison, endothelium-independent vessel function can be similarly calculated by administration of exogenous NO in the form glyceryl trinitrate (GTN).31
Calculation of the Arterial Stiffness and Endothelial Function (
RI)
The DVP waveform consists of a systolic peak (a) and a second diastolic peak (b), which is formed by the reflection of the pulse wave from the small arteries in the lower body (Figure 1). The time delay between the systolic and diastolic peaks is related to the transit time of pressure waves from the root of the subclavian artery to the apparent site of reflection and back to the subclavian artery. The degree of pulse wave reflection (arterial stiffness) depends on the impedance of the microvascular bed and the tone of the large and small blood vessels. This path length can be assumed to be proportional to height; therefore, the index of artery stiffness can be calculated from: arterial stiffness=height/time delay between the systolic and diastolic peaks. The RI is the percentage of systolic pulse wave reflected in each cardiac cycle. Small artery function can be assessed by measuring absolute change in
RI from baseline after salbutamol (Rsal) and GTN (RGTN) administration. RI can be calculated from: RI=a/b and the endothelial function is determined by:
RI=(R–(Rsal)/R)*100.
|
Arterial Stiffness and Endothelial Measurement Protocol
Measurements of arterial stiffness and endothelial function were performed during the morning after an overnight fast (each subject was instructed to refrain from caffeine-containing beverages, alcohol, and smoking in the previous 12 hours), after which the DVP was recorded in the persons right index finger. Subjects were laid supine, resting for at least 20 minutes in a temperature-controlled environment (24±1°C) before the measurements were taken. All the volunteers were advised to refrain from talking and sleeping while the measurements were performed. Recorded digital pulse wave forms were used (PCA 2; MicroMedical) to generate indices of vessel reactivity (RI) and arterial stiffness using a standard validated protocol.32 Each person had at least 3 measurements (recorded for 30 seconds) taken 1 minute apart, and an average was calculated and used for the analysis. Thereafter, subjects were given a predetermined dose of Salbutamol by inhalation (400 micrograms via a spacer device) and sublingual GTN (200 micrograms), each separated by a washout period of 60 minutes. Relative change in RI was monitored at 3-minute intervals for total of 15 minutes. Individuals whose pulse wave recordings could not be adequately assessed or who had arterial stiffness and RI variation >15% within measurements were excluded from the final analysis (11.3%). All of the measurements were performed by the same operator. Intraobserver variation (coefficient of variation) of the repeated measurements of arterial stiffness in the same subject on the same day and 6 weeks later was 5.4% and 7.4%, respectively,25 confirming the findings from recent studies by our group and others that the DVP analysis technique has been shown to have excellent repeatability and reproducibility (mean difference [SD], –0.2 [4.9%]).25
Power Calculation and Statistical Analysis
Based on previous work by our group and other pilot data,22 to have 80% power at P<0.05 and to observe
SD difference in arterial stiffness and RI, at least 60 people were needed in each group.
After being tested for normality using the Kolmogorov-Smirnov test, all the indices measured demonstrated a normal distribution. Data are presented as the mean±SD, and Student t test and 1-way ANOVA tests were used to determine differences between groups with continuous variables. The
2 test was used to compare the categorical variables. In univariate analysis, Pearson correlation was used to test the relationship between arterial stiffness and other cardiovascular risk indices. Linear regression models were used for multivariate analysis. A 2-tailed P<0.05 was considered statistically significant for all comparisons. Data were analyzed using SPSS version v14 (SPSS Inc).
| Results |
|---|
|
|
|---|
|
|
|
Of the total cohort, 9.5% of the stroke patients with clinical symptoms of stroke had normal CT/MRI scan results, without any evidence of ethnic variation. The majority had radiological evidence of fronto-parietal infarctions: 37.1% of the South Asian stroke patients had evidence of anterior circulation infarcts compared to 51.7% of European Caucasians (P>0.05). The majority of the South Asians had normal duplex scan results (76.3% vs 36.7%; P<0.001). Of the patients with abnormal scan findings, 20.1% European Caucasians demonstrated evidence of significant carotid artery stenosis (>50%; Table 1![]()
).
Stroke Severity, Functional Status, and Stroke Subtypes
At baseline and according to the Scandinavian Neurological Stroke scale and modified Rankin scale scores, both ethnic groups had similar stroke severity and functional status (P>0.05). At follow-up, both groups had improvement of their Scandinavian Neurological Stroke scale and modified Rankin scale scores (South Asians, 46.5; SD, 7.8 vs European Caucasian, 43.8; SD, 9.6; P<0.01). Compared to the baseline scores, South Asians had greater improvement of the Scandinavian Neurological Stroke scale score (13.2 vs 5.4; P=0.001) compared to European Caucasians. EQ5D assessment was comparable between both ethnic groups. According to the Bamford and TOAST criteria, South Asians had higher small-vessel and lacunar infarctions, (29.6 vs 15.5; P=0.04) and (32.6 vs 13.3; P=0.01), respectively, compared to European Caucasians. In European Caucasians, 27.6% of the strokes were attributable to cerebral large-vessel disease compared with 16.7% among South Asians (P=0.03; Table 1![]()
).
Stroke Subjects Compared to Risk Factor and Healthy Controls
South Asian stroke survivors had significantly elevated serum cholesterol and plasma glucose levels, as well as body mass index compared to European Caucasians (P<0.05). Blood pressure parameters were comparable. As expected, compared to controls, stroke survivors had significantly higher risk indices (P<0.05), but similar waist-to-hip ratio measurements (Table 2).
|
Measurements of Arterial Stiffness and Endothelial Function
Indices of arterial structure and function were available for 277 (South Asian, 217; European Caucasian, 60) individuals. Of the total cohort, arterial stiffness measurements were significantly higher in South Asian stroke patients compared to European Caucasians (P<0.001; Figure 2). Compared to healthy controls, all other groups had significantly higher arterial stiffness (P<0.001; Table 2). In a separate analysis, comparing South Asian stroke patients vs South Asian risk factor controls, arterial stiffness remained significantly higher among South Asian stroke patients (P=0.002).
|
In a subgroup analysis among South Asians, arterial stiffness was significantly higher in diabetic subjects compared to nondiabetic subjects (P<0.05), whereas RI was significantly lower in diabetic subjects compared to nondiabetic subjects among both ethnic groups (Table 3). On an exploratory analysis of variations in arterial stiffness among different stroke subtypes, South Asian stroke patients with large-vessel disease (total anterior circulation infarct and partial anterior circulation infarct) had significantly higher arterial stiffness compared to European Caucasians (P=0.002). Arterial stiffness was comparable among patients with small-vessel disease (lacunar) infarctions (Table 4).
|
|
The endothelium-dependent vascular function of each individual was calculated by determining the relative change in RI (
RI %) after salbutamol inhalation. South Asian stroke patients had significantly poorer endothelial function when compared to European Caucasians (P<0.001; Figure 2B). As expected, South Asian healthy controls had significantly better endothelial function compared to groups with risk factors (P=0.001). In subgroup analysis, patients with diabetes were demonstrated to have significantly poorer endothelial function in both ethnic groups (P<0.01). However, this difference was most notably present among South Asian individuals with stroke. Furthermore, endothelial function was significantly poorer among South Asian stroke patients with lacunar and large-vessel disease strokes compared to European Caucasians (P<0.01), as shown in Table 4.
Analysis of the South Asian stroke patients according to arterial stiffness and
RI % tertiles revealed that the majority of South Asian stroke survivors with diabetes had the highest arterial stiffness and poorest endothelial function (Figure 3).
|
Correlations and Multivariate Regression
On univariate analysis, there was a significant negative association (R) between arterial stiffness and
RI (R=–0.28; P<0.001) and arterial stiffness and age (R=0.27; P<0.001) for the total population. Arterial stiffness was significantly associated with fasting plasma glucose(R=0.45; P<0.001), total cholesterol (R=0.24; P<0.001), waist-hip ratio (R=0.3; P<0.001), and mean arterial pressure (R=0.2; P=0.002) among South Asians, and with a total cholesterol level (R=0.3; P=0.01) among European Caucasians. There was a negative association between endothelial function and fasting glucose (R=–0.4; P<0.001), total cholesterol (R=–0.18; P=0.03), body mass index (R=–0.2; P=0.007), and WHR (R=–0.17; P=0.02) among South Asians, but no significant association was apparent among European Caucasian stroke survivors.
In a multivariate regression analysis, South Asian ethnicity was independently associated with both arterial stiffness and endothelial function in a stepwise model that included age, gender, diabetes, hypertension, hypercholesteremia, heart rate, waist-to-hip ratio, smoking, and alcohol consumption status (Table 5). In a separate model, South Asian ethnicity was independently associated with diabetic status (β=–0.21; CI, –0.3–0.06; P=0.007), whereas glycemic status was independently associated with both arterial stiffness and endothelial function among South Asians. In these models, only 24% of the endothelial function abnormalities and 15% of the arterial stiffness aberrancies were explained by the presence of traditional risk factors among South Asians (Table 5).
|
| Discussion |
|---|
|
|
|---|
According to the current analysis, South Asian ethnicity per se was a significant risk factor, suggesting an underlying aberrant genetic susceptibility. However, 15% to 24% of the abnormalities were explained by prevalence of traditional risk factors, including glycemic status. Hence, not only is diabetes more common among South Asians compared to other ethnic groups33 but also it is likely that this is a hereditable risk factor in this population.34 In the current study, >40% of the South Asian stroke survivors had evidence of diabetes, and diabetes status was independently associated with South Asian ethnicity. More importantly, patients with diabetes had the greatest vessel wall abnormalities. It is likely that shown independent interactions between diabetic status and South Asian ethnicity may further explain the demonstrated vascular abnormalities. However, endothelial dysfunction independently predicted increased arterial stiffness among South Asians, which in turn was associated with the highest indices of arterial stiffness. Thus, part of the remodeling processes that have occurred in the vessel wall could be attributed by a primary defect in the endothelium.35 Glycemic status has an impact on the endothelium-derived NO production,36 causing a blunted smooth muscle relaxation response in the small to medium vessel walls, with a consequent increase in vessel tone, contributing to increased arterial stiffness.29
This hypothesis is further supported by our findings of the current analysis, after the administration of GTN, both groups had similar reflective indices compared to those produced after Salbutamol administration, indicating similar dilation of the vessels wall in both ethnic groups in the presence of adequate NO availability. NO availability is increased using GTN rather than Salbutamol, because the former is an external NO donor drug, whereas the latter acts on the beta adrenoreceptors of the endothelium to release endogenous NO, where the response is based merely on the functional integrity of the endothelium.38
In addition, the simultaneous presence of other metabolic, inflammatory, and oxidative stress-related abnormalities37 that are known to manifest among South Asians may cause a synchronized (adverse) impact on the vascular system. Adverse diet and lifestyle differences observed in migrant South Asians may further augment this unfavorable risk profile38,39 despite a lower prevalence of smoking. The present study also demonstrates the clear differences in the distribution of stroke subtypes, whereby South Asian stroke patients had more small-vessel disease (lacunar infarctions) compared to more prevalent large-vessel strokes among European Caucasians. This is consistent with other published studies,40,41 particularly among a stroke population with higher prevalence of diabetes. However, De Silva et al42 recently demonstrated higher rates of intracranial large vessel disease, even among patients with lacunar infarctions, using intracranial Doppler imaging. More studies using more sophisticated imaging methods are needed to determine exactly the type of intracranial vascular pathology among South Asian stroke patients.
This is the first study to our knowledge to report indices of stroke severity among South Asian stroke survivors compared to European Caucasians. In the current study, the severity of the stroke was assessed using 2 validated and commonly used scales. The Modified Rankin scale18 provides a score based predominantly on the patients mobility and motor function as a whole, whereas the Scandinavian Neurological Stroke scale19 is more comprehensive in enabling the user to consistently rate all other parameters such as vision, speech, and continence. At presentation, both ethnic groups had similar stroke severity according to both scales. However, South Asian stroke survivors were found to have significant overall improvement assessed by the Scandinavian Neurological Stroke scale score after a similar period of follow-up. Ethnicity has been previously reported as an independent predictor of stroke severity,43 and the possible reasons for this difference merit further investigation.
| Conclusions |
|---|
|
|
|---|
In conclusion, South Asian stroke survivors had more small-vessel disease-related cerebrovascular events compared to European Caucasians. Underlying glycemic status in South Asians had an adverse impact on the vascular system, leading to abnormal vessel wall characteristics.
Received January 22, 2009; accepted February 23, 2009.
| References |
|---|
|
|
|---|
2. Manton KG. The global impact of non-communicable diseases: estimates and projections. World Health Stat Q. 1988; 41: 255–266.[Medline] [Order article via Infotrieve]
3. Tolonen H, Mahonen M, Asplund K, Rastenyte D, Kuulasmaa K, Vanuzzo D, Tuomilehto J. Do trends in population levels of blood pressure and other cardiovascular risk factors explain trends in stroke event rates? WHO MONICA Stroke Project World Health Organization Monitoring of Trends and Determinants in Cardiovascular Disease. Stroke. 2002; 33: 2367–2375.
4. Wild S, Mckeigue P. Cross sectional analysis of mortality by country of birth in England and Wales, 1970–92. BMJ. 1997; 314: 705–710.
5. Gunarathne A, Patel JV, Gammon B, Hughes EA, Lip GY. Ischaemic stroke in South Asians: A review of the epidemiology, pathophysiology and ethnicity-related clinical features. Stroke. 2009; 40: e415–e423.
6. Patel JV, Vyas A, Prabhakaran D, Bhatnagar D, Durrington PN, Heald A, Hughes EA, Mackness MI, Reddy KS, Cruickshank JK. Nonesterified fatty acids as mediators of glucose intolerance in Indian Asian populations. Diabetes Care. 2005; 28: 505–507.
7. Gunarathne A, Patel JV, Potluri R, Gammon B, Jessani S, Hughes EA, Lip GY. Increased 5-year mortality in the migrant South Asian stroke patients with diabetes mellitus in the United Kingdom: the West Birmingham Stroke Project. Int J Clin Pract. 2008; 62: 97–201.[Medline] [Order article via Infotrieve]
8. Gunarathne A, Patel JV, Potluri R, Gill PS, Hughes EA, Lip GY. Secular trends in the cardiovascular risk profile and mortality of stroke admissions in an inner city, multiethnic population in the United Kingdom (1997–2005). J Hum Hypertens. 2008; 22: 18–23.[CrossRef][Medline] [Order article via Infotrieve]
9. Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G. Prognostic significance of endothelial dysfunction in hypertensive patients. Circulation. 2001; 104: 191–196.
10. Laurent S, Katsahian S, Fassot C, Tropeano AI, Laloux B, Boutouyrie P. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003; 34: 1203–1206.
11. Oliver JJ, Webb DJ. Noninvasive assessment of arterial stiffness and risk of atherosclerotic events. Arterioscler Thromb Vasc Biol. 2003; 23: 554–566.
12. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function? Circulation. 2002; 106: 2085–1906.
13. Markus HS, Khan U, Birns J, Evans A, Kalra L, Rudd AG, Wolfe CD, Jerrard-Dunne P. Differences in stroke subtypes between black and white patients with stroke: the South London Ethnicity and Stroke Study. Circulation. 2007; 116: 2157–2164.
14. Hajat C, Tilling K, Stewart JA, Lemic-Stojcevic N, Wolfe CD. Ethnic differences in risk factors for ischemic stroke: a European case-control study. Stroke. 2004; 35: 1562–1567.
15. Hatona S. Experiences from a multicenter stroke register: a preliminary report. Bull World Health Org. 1976; 54: 541–553.[Medline] [Order article via Infotrieve]
16. National Institute of Clinical Excellence (NICE) guidelines for Cardiovascular disease. http://guidance.nice.org.uk/topic/cardiovascular. Accessed February 8, 2008.
17. Glick HA, Polsky D, Willke RJ, Schulman KA. A comparison of preference assessment instruments used in a clinical trial: responses to the visual analog scale from the EuroQol EQ-5D and the Health Utilities Index. Med Decis Making. 1999; 19: 265–275.
18. Wolfe CD, Taub NA, Woodrow EJ, Burney PG. Assessment of scales of disability and handicap for stroke patients. Stroke. 1991; 22: 1242–1244.
19. Lindenstrøm E, Boysen G, Waage Christiansen L, à Rogvi Hansen B, Würtzen Nielsen P. Reliability of Scandinavian Neurological Stroke Scale. Cerebrovasc Dis. 1991; 1: 103.[CrossRef]
21. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1991; 24: 35–41.
22. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. (1991). Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991; 337: 1521–1526.[CrossRef][Medline] [Order article via Infotrieve]
23. http://www.neighbourhood.statistics.gov.uk. Accessed August 3, 2008.
24. Gunarathne A, Patel JV, Gammon B, Hughes EA, Lip GY. Impact of mean arterial blood pressure on higher arterial stiffness indices in South Asians compared to white Europeans. J Hypertens. 2008; 26: 1420–1426.[CrossRef][Medline] [Order article via Infotrieve]
25. Gunarathne A, Patel JV, Hughes EA, Lip GY. Measurement of stiffness index by digital volume pulse analysis technique: clinical utility in cardiovascular disease risk stratification. Am J Hypertens. 2008; 21: 866–872.[CrossRef][Medline] [Order article via Infotrieve]
26. Sollinger D, Mohaupt MG, Wilhelm A, Uehlinger D, Frey FJ, Eisenberger U. Arterial stiffness assessed by digital volume pulse correlates with comorbidity in patients with ESRD. Am J Kidney Dis. 2006; 48: 456–463.[CrossRef][Medline] [Order article via Infotrieve]
27. Millasseau SC, Kelly RP, Ritter JM, Chowienczyk PJ. Determination of age-related increases in large artery stiffness by digital pulse contour analysis. Clin Sci (Lond). 2002; 103: 371–377.[Medline] [Order article via Infotrieve]
28. Woodman RJ, Kingwell BA, Beilin LJ, Hamilton SE, Dart AM, Watts GF, Am J. Assessment of central and peripheral arterial stiffness: studies indicating the need to use a combination of techniques. Hypertension. 2005; 18: 249–260.[CrossRef]
29. Chowienczyk PJ, Kelly RP, MacCallum H, Millasseau SC, Andersson TL, Gosling RG, Ritter JM, Anggård EE. Photoplethysmographic assessment of pulse wave reflection: blunted response to endothelium-dependent beta2-adrenergic vasodilation in type II diabetes mellitus. J Am Coll Cardiol. 1999; 34: 2007–2014.
30. Rambaran C, Jiang B, Ritter JM, Shah A, Kalra L, Chowienczyk PJ. Assessment of endothelial function: comparison of the pulse wave response to beta 2-adrenoceptor stimulation with flow mediated dilatation. Br J Clin Pharmacol. 2008; 65: 238–243.[CrossRef][Medline] [Order article via Infotrieve]
31. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Mang K, Morgan JJ, Avolio AP. Nitroglycerin has more favorable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J. 1990; 11: 138–144.
32. Millasseau SC, Ritter JM, Takazawa K, Chowienczyk PJ. Contour analysis of the photoplethysmographic pulse measured at the finger. J Hypertens. 2006; 24: 1449–1456.[Medline] [Order article via Infotrieve]
33. Patel JV, Gunarathne A, Lane D, Lim HS, Tracey I, Panja NC, Lip GY, Hughes EA. Widening access to cardiovascular healthcare: community screening among ethnic minorities in inner-city Britain. BMC Health Serv Res. 2007; 7: 1.[CrossRef][Medline] [Order article via Infotrieve]
34. Moussouttas M, Aguilar L, Fuentes K, Anyanwu B, Manassarians H, Papamitsakis N, Shi Q, Visintainer P. Cerebrovascular disease among patients from the Indian subcontinent. Neurology. 2006; 67: 894–896.
35. Guerci B, Böhme P, Kearney-Schwartz A, Zannad F, Drouin P. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab. 2001; 27: 436–447.[Medline] [Order article via Infotrieve]
36. Calver A, Collier J, Vallance P. Inhibition and stimulation of nitric oxide synthesis in the human forearm arterial bed of patients with insulin dependent diabetes. J Clin Invest. 1992; 90: 2548–2554.[Medline] [Order article via Infotrieve]
37. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord. 2001; 25: 1327–1331.[CrossRef][Medline] [Order article via Infotrieve]
38. Lean ME, Han TS, Bush H, Anderson AS, Bradby H, Williams R. Ethnic differences in anthropometric and lifestyle measures related to coronary heart disease risk between South Asian, Italian and general-population British women living in the west of Scotland. Int J Obes Relat Metab Disord. 2001; 25: 1800–1805.[CrossRef][Medline] [Order article via Infotrieve]
39. Lip GY, Luscombe C, McCarry M, Malik I, Beevers G. Ethnic differences in public health awareness, health perceptions and physical exercise: implications for heart disease prevention. Ethn Health. 1996; 1: 47–53.[Medline] [Order article via Infotrieve]
40. Syed NA, Khealani BA, Ali S, Hasan A, Akhtar N, Brohi H, Mozaffar T, Ahmed N, Hameed A, Baig SM, Wasay M. Ischemic stroke subtypes in Pakistan: the Aga Khan University Stroke Data Bank. J Pak Med Assoc. 2003; 53: 584–588.[Medline] [Order article via Infotrieve]
41. Deleu D, Hamad AA, Kamram S, El Siddig A, Al Hail H, Hamdy SM. Ethnic variations in risk factor profile, pattern and recurrence of non-cardioembolic ischemic stroke. Arch Med Res. 2006; 37: 655–662.[CrossRef][Medline] [Order article via Infotrieve]
42. De Silva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke. 2007; 38: 2592–2594.
43. Jones MR, Horner RD, Edwards LJ, Hoff J, Armstrong SB, Smith-Hammond CA, Matchar DB, Oddone EZ. Racial variation in initial stroke severity. Stroke. 2000; 31: 563–567.
44. Stewart JA, Dundas R, Howard RS, Rudd AG, Wolfe CD. Ethnic differences in incidence of stroke: prospective study with stroke register. BMJ. 1999; 318: 967–971.
45. Hsu RT, Ardron ME, Brooks W, Cherry D, Taub NA, Botha JL. The 1996 Leicestershire Community Stroke & Ethnicity Study: differences and similarities between South Asian and white strokes. Int J Epidemiol. 1999; 28: 853–858.
46. National Statistics Online.UK census 2004. http://www.statistics.gov.uk. Accessed February 8, 2006.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |